Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes
- 5 May 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Urology and Nephrology
- Vol. 95 (8), 868-1342
- https://doi.org/10.1007/s11255-017-1609-8
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory studyThe Lancet, 2017
- Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patientsBJU International, 2016
- Impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsyInternational Journal of Urology, 2014
- Value of Prostate Specific Antigen Density and Percent Free Prostate Specific Antigen for Prostate Cancer PrognosisJournal of Urology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Multi-Parametric Magnetic Resonance Imaging to Rule-In and Rule-Out Clinically Important Prostate Cancer in Men at Risk: A Cohort StudyUrologia Internationalis, 2011
- Interobserver Variability of Transrectal Ultrasound for Prostate Volume Measurement According to Volume and Observer ExperienceAmerican Journal of Roentgenology, 2009
- The Performance of Prostate Specific Antigen, Prostate Specific Antigen Density and Transition Zone Density in the Era of Extended Biopsy SchemesJournal of Urology, 2008
- Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imagingJapanese Journal of Clinical Oncology, 1998
- Prostate Specific Antigen Density: A Means of Distinguishing Benign Prostatic Hypertrophy and Prostate CancerJournal of Urology, 1992